GHRP-6

GHRP-6 is a synthetic hexapeptide and the first member of the GHRP family to be widely studied. Like GHRP-2, it acts on the ghrelin/GHS-R1a receptor to stimulate growth hormone release from the pituitary. It is most famous for its powerful appetite-stimulating effect — even more pronounced than GHRP-2. It is sold strictly for laboratory research.

GHRP-6 is the granddaddy of the GHRP family — the first peptide developed in this category, decades ago. It reliably triggers a growth hormone pulse, but its most noticeable real-world effect is hunger. Users routinely describe a dramatic appetite spike within 30–60 minutes of administration. Modern research stacks have largely replaced GHRP-6 with cleaner alternatives like ipamorelin, but it still has its niche, particularly for users who actively want appetite stimulation.

GHRP-6 binds the ghrelin receptor (GHS-R1a) on pituitary somatotrophs, triggering GH release via the same calcium-mediated pathway as GHRP-2 and ipamorelin. The strong appetite effect comes from the same receptor activation in the hypothalamus, where ghrelin signaling drives hunger.

First-generation GHS. Powerful ghrelin activation = extreme appetite induction.

1. GHRP-6
2. GHRH and/or ghrelin receptors in the pituitary
3. Pulsatile growth hormone release
4. Downstream IGF-1, body-composition and recovery endpoints

A plain-English read on how much published evidence currently exists for GHRP-6. These ratings describe the volume and maturity of the literature — not effectiveness, safety, or suitability for any use.

Current limitations: most compounds in this category are studied in preclinical or small-sample settings. Absence of large controlled human trials is the single biggest limitation to keep in mind when reading any summary of GHRP-6.

Lyophilized compounds are supplied as a dry powder. Concentration is simply the total amount in the vial divided by the volume of bacteriostatic water added:

Concentration (mg/mL) = total mg in vial ÷ mL of diluent added

Commonly supplied vial sizes

5mg vial

Worked concentration example

5mg + 2mL BAC water → 2.5mg/mL On U-100 insulin syringe:

• • 4 units = 100mcg

Run your own numbers with the reconstitution calculator — it converts vial size and diluent volume into mg/mL and mcg/mL.

The figures below are reported here descriptively, because they are the values most frequently cited in publicly available research literature and reference material. They are not instructions, not a protocol, and not a recommendation. These compounds are supplied for laboratory research use only and are not approved by the FDA for human consumption.

Commonly cited amounts

100mcg, 2–3× daily subcutaneous

Commonly cited frequency

2–3× daily — hunger hits 30–60 min after injection

Commonly cited study duration

8–12 weeks

Peptides are supplied freeze-dried because peptide bonds degrade far faster in solution than in a dry state. Understanding storage is part of understanding why the powder form exists at all.

• •Lyophilized powder: stored refrigerated, typically stable for months to years.
• •Reconstituted solution: refrigerated at 2–8°C, generally discussed as stable for roughly 30–60 days.
• •Heat and direct light accelerate degradation — vials are kept cool and dark.
• •Reconstituted material is not re-frozen; ice crystal formation disrupts peptide structure.
• •Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, which is what allows multi-day storage after reconstitution.

More detail in the storage & handling guide and how peptide quality is evaluated.

• •Pulsatile GH release pharmacology
• •Ghrelin receptor and appetite biology
• •Cachexia and appetite stimulation research
• •Comparative GHRP pharmacology
• •Cortisol and prolactin effects in long-term protocols

GHRP-6 is mostly mentioned for historical context or by users specifically chasing appetite stimulation — bodybuilders in bulking phases who want to eat more, or researchers studying cachexia. It is generally regarded as outdated for routine GH-pulse research compared to ipamorelin.

“The hungry-peptide that started the GHRP family.”

Combined with CJC-1295 (with or without DAC) for synergistic GH release. Rarely combined with ipamorelin because the two compete at the same receptor.

GHRP-6 is the original GHRP — a ghrelin-receptor-binding hexapeptide that stimulates growth hormone release and strongly increases appetite. Largely replaced by ipamorelin for clean GH pulse research, it remains useful where appetite stimulation is desired. Sold for laboratory research only.